Equities

Kelyniam Global Inc

KLYG:PKC

Kelyniam Global Inc

Actions
  • Price (USD)0.07
  • Today's Change0.00 / 0.00%
  • Shares traded11.50k
  • 1 Year change-12.50%
  • Beta-1.2531
Data delayed at least 15 minutes, as of Jul 02 2024 16:27 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Kelyniam Global, Inc. is a custom design-to-build medical device manufacturing company. The Company specializes in the delivery of cranial implant technologies to neurologically dependent patients. The Company is engaged in the production of custom prosthetics utilizing computer-aided design and computer-aided manufacturing of medical-grade polymers. Its Engineering Division uses Bio-Computer Aided Design (CAD) Computer Aided Manufacturing (CAM) technology to provide replicated cranial implants to replace damaged bone structures. Its product, PEEK-Optima, is engineered for biocompatibility. Derived from the patient’s computed tomography (CT) data, the Company’s 3D BIO-CAD/CAM software is used to transfer the details found on the edge of the defect directly to the implant edge. Its K-Plans include ke24, ke72 and kp5day. The Company’s emergency plan, ke24, provides precision-replicated, patient-specific cranial implants in approximately 24 hours.

  • Revenue in USD (TTM)517.70k
  • Net income in USD-420.28k
  • Incorporated2005
  • Employees0.00
  • Location
    Kelyniam Global Inc97 River RdCOLLINSVILLE 06019-3246United StatesUSA
  • Phone+1 (800) 280-8192
  • Fax+1 (501) 641-2000
  • Websitehttps://kelyniam.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Grapefruit USA Inc34.85k-4.37m1.66m9.00------47.63-0.008-0.0080.00006-0.01010.01211.310.22593,872.22-151.85-268.93-----1,304.65-10.09-12,531.68-408.870.0388-1.50-----83.9677.87-35.68------
Nemaura Medical Inc0.00-10.65m1.67m36.00---------0.3787-0.37870.00-0.61690.000.00--0.00-117.49-58.18---131.96-------7,384.830.0305-1.4710.81---84.71---1.85--64.14--
Leafbuyer Technologies Inc5.22m-957.96k1.74m14.00------0.3337-0.0097-0.00970.053-0.01733.24--51.22372,680.00-59.51-62.47----35.7633.53-18.36-62.40---6.16----33.7235.17-161.23------
SETO Holdings Inc4.96m-652.00k1.83m18.00--0.1657--0.3682-0.056-0.0560.39940.1341.572.658.51---20.703.84-29.075.9552.8352.44-13.153.920.99211.240.3040.0019.015.44-61.23------
DermTech Inc15.66m-89.63m1.92m206.00--0.0481--0.1228-2.69-2.690.46521.140.111911.925.0676,038.84-64.00---71.29--8.51---572.19--3.46--0.0013--5.36--13.54------
NanoVibronix Inc2.85m-3.20m2.00m10.00--0.5721--0.7034-1.72-1.721.451.260.5160.368313.64285,000.00-57.98-116.16-101.17-169.3668.9850.47-112.35-570.471.38-13.470.00--203.5948.3331.88---34.02--
Nuwellis Inc8.90m-19.93m2.07m59.00--30.89--0.2331-8.30-8.302.730.13040.70761.557.04150,762.70-143.62-98.07-216.07-122.4857.4155.22-202.97-230.510.7092-4.750.00--3.7612.14-55.78--4.61--
Kelyniam Global Inc517.70k-420.28k2.10m0.00--3.92--4.05-0.0253-0.02530.03120.01790.41357.044.38---33.57---41.79--18.86---81.18--1.26--0.6232---26.47---19.10------
Citrine Global Corp0.00-2.38m2.12m18.00---------0.0025-0.00250.00-0.00280.00----0.00-173.12-298.98---964.26-------4,814.84---5.41--------41.43---5.44--
InnerScope Hearing Technologies, Inc.334.45k-7.15m2.14m24.00------6.40-0.0153-0.01530.0002-0.00280.09553.931.71---204.11-27.82---94.5317.7958.17-2,138.50-42.130.0022-0.4232------100.59----233.50--
Tivic Health Systems Inc1.13m-7.61m2.28m9.00--0.252--2.01-11.17-11.171.021.460.21840.923717.31126,000.00-146.51---194.55--30.07---670.99--2.07--0.00---36.09--18.34------
LumiraDx Ltd126.52m-338.03m2.30m1.21k------0.0182-1.08-1.080.4021-1.310.27651.792.44104,557.90-73.83---96.82---80.48---267.03--1.01-10.512.14---39.62---343.67------
Helius Medical Technologies Inc-100.00bn-100.00bn2.34m26.00--0.4139----------2.24-----------98.37---143.57--37.27---1,580.663.26-------18.176.1437.11------
Bioelectronics Corp1.61m-289.82k2.47m9.00------1.53-0.00002-0.000020.00007-0.00066.329.2014.53---113.86-383.59----49.4351.48-18.01-143.480.0099-0.4909----94.01-5.0975.01------
Data as of Jul 02 2024. Currency figures normalised to Kelyniam Global Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.